‘Pharma Wholesale And Distribution Market Worth $1,195bn In 2021’ Says Visiongain Report

16 August 2018
Pharma

Visiongain’s new report Pharma Wholesale and Distribution Market Forecasts 2017-2027: Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China indicates that the pharma wholesale and distribution market will see $1,195bn in spending in 2021.

The pharma wholesale and distribution market is estimated at $893.69bn in 2016 and is expected to grow at a CAGR of 6.0% in the first half of the forecast period. The market is expected to grow at a CAGR of 5.2% from 2017-2027. In 2016, the branded drugs submarket held 79.5% share of the pharma wholesale and distribution market.
The lead analyst of this report said “The pharmaceutical wholesale and distribution market will be driven by an overall increased demand for pharmaceuticals. This is a result of the growing ageing population in developed countries and the increasing access to healthcare of the expanding middle class in the emerging economies.
Market expansion will be partially offset by reduced revenue generation of branded products as patents expire and cheaper generic version become available. Additionally, specialty products will continue to generate revenue, even after their patent protection is lost owing to the complexity of copying these products.”
The 265-page report contains 83 tables and 97 figures that add visual analysis in order to explain the developing trends within the pharma wholesale and distribution market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the pharma wholesale and distribution market and its leading submarkets: Branded Drugs, Generic Drugs, Other Medicines.
The 265-page report offers market forecasts for the leading national markets: US, Germany, France, The UK, Italy, Spain, Japan, China, Brazil, Russia and India
Moreover, our work discusses the leading companies in the pharma wholesale and distribution market. Our study also includes SWOT and STEP analysis of this industry and market.

The report Pharma Wholesale and Distribution Market Forecasts 2017-2027: Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China report will be of value to anyone who wants to better understand the pharma wholesale and distribution market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the pharma wholesale and distribution market.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

Read

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

Read

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

11 January 2021

Read

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever